(Q38267176)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25387473%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

review article

1 reference

title

Polyunsaturated fatty acids and their metabolites in brain function and disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25387473%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25387473%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Richard P Bazinet

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25387473%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

12 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25387473%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Neuroscience

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25387473%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25387473%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25387473%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

771-785

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25387473%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrn3820

22 February 2020

exact match

0 references

cites work

Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo

1 reference

Fatty acid transport into the brain: of fatty acid fables and lipid tails

31 March 2020

1 reference

Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid

31 March 2020

1 reference

β-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels

31 March 2020

1 reference

Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways

31 March 2020

1 reference

Regioisomers of phosphatidylcholine containing DHA and their potential to deliver DHA to the brain: role of phospholipase specificities

31 March 2020

1 reference

A model for fatty acid transport into the brain.

31 March 2020

1 reference

The fatty acid transport protein (FATP) family: very long chain acyl-CoA synthetases or solute carriers?

31 March 2020

1 reference

Cellular fatty acid uptake: the contribution of metabolism

31 March 2020

1 reference

CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but not transport across the plasma membrane

31 March 2020

1 reference

Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36

31 March 2020

1 reference

Fetal intrauterine whole body linoleic, arachidonic and docosahexaenoic acid contents and accretion rates.

31 March 2020

1 reference

An assessment of dietary docosahexaenoic acid requirements for brain accretion and turnover during early childhood

31 March 2020

1 reference

Dietary omega 3 fatty acids and the developing brain

31 March 2020

1 reference

Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status

31 March 2020

1 reference

Improving the neurodevelopmental outcomes of low-birthweight infants.

31 March 2020

1 reference

The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects.

31 March 2020

1 reference

Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver

31 March 2020

1 reference

31 March 2020

Fatty acid activation

1 reference

Long-chain acyl-CoA synthetases and fatty acid channeling

31 March 2020

1 reference

Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast

31 March 2020

1 reference

Fatty acid binding proteins in brain development and disease

31 March 2020

1 reference

A novel lysophosphatidic acid acyltransferase enzyme (LPAAT4) with a possible role for incorporating docosahexaenoic acid into brain glycerophospholipids

31 March 2020

1 reference

Substrates of energy metabolism of the pituitary and pineal glands.

31 March 2020

1 reference

Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain

31 March 2020

1 reference

Oxygen radicals shaping evolution: Why fatty acid catabolism leads to peroxisomes while neurons do without it

31 March 2020

1 reference

Inhibiting mitochondrial β-oxidation selectively reduces levels of nonenzymatic oxidative polyunsaturated fatty acid metabolites in the brain.

31 March 2020

1 reference

Phospholipase A2 structure/function, mechanism, and signaling

31 March 2020

1 reference

Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues

31 March 2020

1 reference

Role of Ca2+-independent phospholipase A2 and n-3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation.

31 March 2020

1 reference

The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids

31 March 2020

1 reference

Energy consumption by phospholipid metabolism in mammalian brain

31 March 2020

1 reference

A transduction pathway associated with receptors coupled to the inhibitory guanine nucleotide binding protein Gi that amplifies ATP-mediated arachidonic acid release

31 March 2020

1 reference

Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis

31 March 2020

1 reference

NMDA receptors activate the arachidonic acid cascade system in striatal neurons

31 March 2020

1 reference

Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction

31 March 2020

1 reference

Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade

31 March 2020

1 reference

Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases

31 March 2020

1 reference

Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans

31 March 2020

1 reference

Brain fixation for analysis of brain lipid-mediators of signal transduction and brain eicosanoids requires head-focused microwave irradiation: an historical perspective

31 March 2020

1 reference

Pro-resolving lipid mediators are leads for resolution physiology

31 March 2020

1 reference

Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models

31 March 2020

1 reference

Modulation of inflammation in brain: a matter of fat.

31 March 2020

1 reference

Unesterified docosahexaenoic acid is protective in neuroinflammation

31 March 2020

1 reference

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

31 March 2020

1 reference

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

31 March 2020

1 reference

The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans

31 March 2020

1 reference

Hypothalamic sensing of fatty acids

31 March 2020

1 reference

Leptin-regulated endocannabinoids are involved in maintaining food intake

31 March 2020

1 reference

An endocannabinoid mechanism for stress-induced analgesia.

31 March 2020

1 reference

Mechanisms of action of docosahexaenoic acid in the nervous system

31 March 2020

1 reference

The structure of DHA in phospholipid membranes

31 March 2020

1 reference

N-3 fatty acids and membrane microdomains: from model membranes to lymphocyte function

31 March 2020

1 reference

Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?

31 March 2020

1 reference

Peripheral gating of pain signals by endogenous lipid mediators

31 March 2020

1 reference

Endocannabinoid signaling in microglial cells

31 March 2020

1 reference

Endocannabinoid signaling and synaptic function

31 March 2020

1 reference

Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens

31 March 2020

1 reference

Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets

31 March 2020

1 reference

Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice.

31 March 2020

1 reference

n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice

31 March 2020

1 reference

Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells

31 March 2020

1 reference

Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice

31 March 2020

1 reference

Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions.

31 March 2020

1 reference

Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model

31 March 2020

1 reference

Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease

31 March 2020

1 reference

Regulation of SNARE fusion machinery by fatty acids.

31 March 2020

1 reference

Dietary polyunsaturated fat that is low in (n-3) and high in (n-6) fatty acids alters the SNARE protein complex and nitrosylation in rat hippocampus.

31 March 2020

1 reference

Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3

31 March 2020

1 reference

Syntaxin 3 and SNAP-25 pairing, regulated by omega-3 docosahexaenoic acid, controls the delivery of rhodopsin for the biogenesis of cilia-derived sensory organelles, the rod outer segments

31 March 2020

1 reference

DHA enhances the noradrenaline release by SH-SY5Y cells

31 March 2020

1 reference

Omega-3 fatty acids and rodent behavior

31 March 2020

1 reference

Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect

31 March 2020

1 reference

Docosahexaenoic acid promotes neurite growth in hippocampal neurons

31 March 2020

1 reference

Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function

31 March 2020

1 reference

A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development

31 March 2020

1 reference

N-Docosahexaenoylethanolamine is a potent neurogenic factor for neural stem cell differentiation

31 March 2020

1 reference

Docosahexaenoic acid and the aging brain

31 March 2020

1 reference

A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease

31 March 2020

1 reference

Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats

31 March 2020

1 reference

n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism.

31 March 2020

1 reference

Impact of ω-3 fatty acids in Parkinson's disease

31 March 2020

1 reference

n-3 Polyunsaturated fatty acids in animal models with neuroinflammation

31 March 2020

1 reference

Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke

31 March 2020

1 reference

Polyunsaturated fatty acids, neuroinflammation and well being.

31 March 2020

1 reference

Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice.

31 March 2020

1 reference

Transgenic increase in n-3/n-6 fatty acid ratio protects against cognitive deficits induced by an immune challenge through decrease of neuroinflammation.

31 March 2020

1 reference

Accumulation of dietary docosahexaenoic acid in the brain attenuates acute immune response and development of postischemic neuronal damage.

31 March 2020

1 reference

Modulation of amyloid-β-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid

31 March 2020

1 reference

Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats

31 March 2020

1 reference

Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus.

31 March 2020

1 reference

Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acid

31 March 2020

1 reference

Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice.

31 March 2020

1 reference

Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization

31 March 2020

1 reference

Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats.

31 March 2020

1 reference

Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers

31 March 2020

1 reference

Nutritional n-3 PUFAs deficiency during perinatal periods alters brain innate immune system and neuronal plasticity-associated genes.

31 March 2020

1 reference

Neuroinflammation and memory: the role of prostaglandins

31 March 2020

1 reference

Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain

31 March 2020

1 reference

Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappa B pathway and downstream enzymes involved in prostaglandin biosynthesis

31 March 2020

1 reference

Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2.

31 March 2020

1 reference

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

31 March 2020

1 reference

Prostaglandins and leukotrienes: advances in eicosanoid biology

31 March 2020

1 reference

Inflammatory, apoptotic, and survival gene signaling in Alzheimer's disease. A review on the bioactivity of neuroprotectin D1 and apoptosis

31 March 2020

1 reference

(n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats.

31 March 2020

1 reference

n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier

31 March 2020

1 reference

Brain phospholipid arachidonic acid half-lives are not altered following 15 weeks of N-3 polyunsaturated fatty acid adequate or deprived diet

31 March 2020

1 reference

Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex

31 March 2020

1 reference

Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids

31 March 2020

1 reference

Artificial rearing with docosahexaenoic acid and n-6 docosapentaenoic acid alters rat tissue fatty acid composition

31 March 2020

1 reference

An extraordinary degree of structural specificity is required in neural phospholipids for optimal brain function: n-6 docosapentaenoic acid substitution for docosahexaenoic acid leads to a loss in spatial task performance

31 March 2020

1 reference

Fish, docosahexaenoic acid and Alzheimer's disease

31 March 2020

1 reference

Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder

31 March 2020

1 reference

Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder

31 March 2020

1 reference

Linking lipids to Alzheimer's disease: cholesterol and beyond

31 March 2020

1 reference

A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression

31 March 2020

1 reference

Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease

31 March 2020

1 reference

Brain lipid concentrations in bipolar disorder

31 March 2020

1 reference

Long-chain omega-3 fatty acid deficiency in mood disorders: rationale for treatment and prevention

31 March 2020

1 reference

Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels

31 March 2020

1 reference

Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood.

31 March 2020

1 reference

Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression

31 March 2020

1 reference

A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of Antidepressant Efficacy of Omega-3 Fatty Acids

31 March 2020

1 reference

EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials

31 March 2020

1 reference

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis

31 March 2020

1 reference

One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats

31 March 2020

1 reference

Omega-3 fatty acids and monoamine neurotransmission

31 March 2020

1 reference

Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets

31 March 2020

1 reference

Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat.

31 March 2020

1 reference

Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency

31 March 2020

1 reference

Relationship between the hypothalamic-pituitary-adrenal-axis and fatty acid metabolism in recurrent depression.

31 March 2020

1 reference

Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial

31 March 2020

1 reference

Fish oil prevents the adrenal activation elicited by mental stress in healthy men.

31 March 2020

1 reference

Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers.

31 March 2020

1 reference

Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats

31 March 2020

1 reference

Chronic ω-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol.

31 March 2020

1 reference

Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion

31 March 2020

1 reference

Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment

31 March 2020

1 reference

n-3 LCPUFA improves cognition: the young, the old and the sick

31 March 2020

1 reference

Role of docosahexaenoic acid in maternal and child mental health

31 March 2020

1 reference

Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder

31 March 2020

1 reference

Influences of micronutrient and omega-3 fatty acid supplementation on cognition, learning, and behavior: methodological considerations and implications for children and adolescents in developed societies

31 March 2020

1 reference

Low blood long chain omega-3 fatty acids in UK children are associated with poor cognitive performance and behavior: a cross-sectional analysis from the DOLAB study

31 March 2020

1 reference

The relationship of docosahexaenoic acid (DHA) with learning and behavior in healthy children: a review

31 March 2020

1 reference

Long term adequate n-3 polyunsaturated fatty acid diet protects from depressive-like behavior but not from working memory disruption and brain cytokine expression in aged mice.

31 March 2020

1 reference

An n-3 fatty acid deficient diet affects mouse spatial learning in the Barnes circular maze

31 March 2020

1 reference

DHA supplementation enhances high-frequency, stimulation-induced synaptic transmission in mouse hippocampus.

31 March 2020

1 reference

Maternal intake of Omega-3 essential fatty acids improves long term potentiation in the dentate gyrus and Morris water maze performance in rats.

31 March 2020

1 reference

Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?

31 March 2020

1 reference

Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex

31 March 2020

1 reference

ω-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression

31 March 2020

1 reference

Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging.

31 March 2020

1 reference

Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe

31 March 2020

1 reference

Serum fatty-acid composition and the risk of Alzheimer's disease: a longitudinal population-based study.

31 March 2020

1 reference

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

31 March 2020

1 reference

Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study

31 March 2020

1 reference

Effects of ω-3 fatty acids on cognitive performance: a meta-analysis

31 March 2020

1 reference

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

31 March 2020

1 reference

Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4.

31 March 2020

1 reference

Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men.

31 March 2020

1 reference

Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2

31 March 2020

1 reference

A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model.

31 March 2020

1 reference

Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels.

31 March 2020

1 reference

Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models

31 March 2020

1 reference

Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies

31 March 2020

1 reference

What was lost in translation in the DHA trial is whom you should intend to treat

31 March 2020

1 reference

Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment

31 March 2020

1 reference

Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia

31 March 2020

1 reference

Abnormalities in the fatty acid composition of the postmortem entorhinal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder

31 March 2020

1 reference

Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients

31 March 2020

1 reference

Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications

31 March 2020

1 reference

Elevated delta-6 desaturase (FADS2) expression in the postmortem prefrontal cortex of schizophrenic patients: relationship with fatty acid composition.

31 March 2020

1 reference

Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype

31 March 2020

1 reference

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial

31 March 2020

1 reference

Lipid signalling in disease.

31 March 2020

1 reference

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.

31 March 2020

1 reference

Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients

31 March 2020

1 reference

Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials

31 March 2020

1 reference

The omega-3 fatty acid-derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis

31 March 2020

1 reference

A minimum of 3 months of dietary fish oil supplementation is required to raise amygdaloid afterdischarge seizure thresholds in rats--implications for treating complex partial seizures.

31 March 2020

1 reference

Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses.

31 March 2020

1 reference

Brain-Targeting Form of Docosahexaenoic Acid for Experimental Stroke Treatment: MRI Evaluation and Anti-Oxidant Impact

31 March 2020

1 reference

Omega-3 fatty acids improve recovery, whereas omega-6 fatty acids worsen outcome, after spinal cord injury in the adult rat

31 March 2020

1 reference

DHA metabolism: targeting the brain and lipoxygenation

31 March 2020

1 reference

Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway

31 March 2020

1 reference

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial

31 March 2020

1 reference

Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate

31 March 2020

1 reference

A case of human linolenic acid deficiency involving neurological abnormalities

31 March 2020

1 reference

Membrane docosahexaenoate is supplied to the developing brain and retina by the liver

31 March 2020

1 reference

Whole body synthesis rates of DHA from α-linolenic acid are greater than brain DHA accretion and uptake rates in adult rats

31 March 2020

1 reference

A comparison of the metabolism of eighteen-carbon 13C-unsaturated fatty acids in healthy women

31 March 2020

1 reference

Where does the developing brain obtain its docosahexaenoic acid? Relative contributions of dietary alpha-linolenic acid, docosahexaenoic acid, and body stores in the developing rat.

31 March 2020

1 reference

Brain docosahexaenoate accretion in fetal baboons: bioequivalence of dietary alpha-linolenic and docosahexaenoic acids.

31 March 2020

1 reference

Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation.

31 March 2020

1 reference

Effect of docosahexaenoic acid on the synthesis of phosphatidylserine in rat brain in microsomes and C6 glioma cells.

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRN3820

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25387473%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25387473%20AND%20SRC:MED&resulttype=core&format=json